REFERENCES
- Casey, J. 2020, October 7. COVID-19 and “pandemic exceptionalism”: The tension between taking quick action and collecting data in urgent medical settings. WCG webinar. Accessed October 23, 2020. https://goto.webcasts.com/viewer/event.jsp?ei=1376401&tp_key=9a0c8ce2b3.
- Faden, R. R., N. E. Kass, S. N. Goodman, P. Pronovost, S. Tunis, and T. L. Beauchamp. 2013. An ethics framework for a learning health care system: A departure from traditional research ethics and clinical ethics. Hastings Center Report 43 (s1):S16–S27. doi:10.1002/hast.134.
- London, A. J. 2019. Social value, clinical equipoise and research in a public health setting. Bioethics 33 (3):326–34. doi:10.1111/bioe.12467.
- London, A. J. 2021. Self-defeating codes of medical ethics and how to fix them: Failures in COVID-19 response and beyond. American Journal of Bioethics 21 (1):4–13. doi: 10.1080/15265161.2020.1845854.
- Marquis, D. 1999. How to resolve an ethical dilemma concerning randomized clinical trials. The New England Journal of Medicine 341 (9):691–3. doi:10.1056/NEJM199908263410912.
- Menikoff, J. 2019. How conducting “usual care” research might affect obtaining consent. The American Journal of Bioethics 19 (4):1–3. doi:10.1080/15265161.2019.1590037.
- Menikoff, J., with E. P. Richards. 2006. What the doctor didn’t say: The hidden truth about medical research. Oxford, UK; New York, NY: Oxford University Press.
- United States vs. Rutherford. 1979. 442 U.S. 544 (1979).